CN Patent

CN107737105A — 一种鼻腔用盐酸氮卓斯汀组合物喷雾剂及生产工艺

Assigned to GUIZHOU YUNFENG PHARMACEUTICAL CO Ltd · Expires 2018-02-27 · 8y expired

What this patent protects

本发明公开了一种鼻腔用含盐酸氮卓斯汀的组合物,其特征在于：其组分包含：氮卓斯汀或其药用盐、糖皮质激素和其他辅料，其中100毫升该组合物中包含：氮卓斯汀或其药用盐0.05‑5g、糖皮质激素0.1‑2g。主要是解决共同抗过敏，起效速度快和减少单一激素用药的副作用。稳定的化学性质、低的刺激性、可用于治疗鼻炎和其它与过敏性和非过敏性疾病相关的症状例如过敏性和/或接触性皮炎等。

USPTO Abstract

本发明公开了一种鼻腔用含盐酸氮卓斯汀的组合物,其特征在于：其组分包含：氮卓斯汀或其药用盐、糖皮质激素和其他辅料，其中100毫升该组合物中包含：氮卓斯汀或其药用盐0.05‑5g、糖皮质激素0.1‑2g。主要是解决共同抗过敏，起效速度快和减少单一激素用药的副作用。稳定的化学性质、低的刺激性、可用于治疗鼻炎和其它与过敏性和非过敏性疾病相关的症状例如过敏性和/或接触性皮炎等。

Drugs covered by this patent

Patent Metadata

Patent number
CN107737105A
Jurisdiction
CN
Classification
—
Expires
2018-02-27
Drug substance claim
No
Drug product claim
No
Assignee
GUIZHOU YUNFENG PHARMACEUTICAL CO Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.